philips cartridge engineer - closes 12/5/2013, page-18

The most important point in this whole scenario in my opinion is the following :

* Philips/Biomerieux partner to develop a device "Magnotech" for use in the POC Market initially targeting the $1B + pa Troponin (Cardiac) Testing market

* This device obviously has had development troubles and a solution needed to be found

* This Solution IMO is Mixngo - Anteos patented Molecular glue

* The value I put on the company as a result of this (If it proves to be the case) Is that Mixngo and Anteo as a company is highly VALUABLE

* What value do you put on a product that determines whether a company can make hundreds of millions in revenue or without Mixngo they make ZERO

* The value is not in this deal alone but what it will do in other scenarios for other companies

* This could not be any clearer but that is just my opninion